NeuroVive Pharmaceutical AB (NeuroVive) is a pharmaceutical company that offers products for injury. The company research and develops pharmaceuticals to protect mitochondria from post acute traumatic injury. Its drug development technology platform comprises cyclosporine-A for the treatment of acute traumatic conditions. NeuroVive conducts clinical trials of CicloMulsion and NeuroSTAT in humans. The company’s research program concentrates on developing additional variants of cyclophilin-D-inhibiting cyclosporines based pharmaceuticals. Its cyclosporine reduces the level of secondary tissue damage after a traumatic injury by mitochondrial protection. The company was formerly known as Neuro Pharma. NeuroVive is headquartered in Lund, Sweden.